1. Gandhi SK, Hanson MM, Vernava AM, Kaminski DL, Longo WE. Ischemic colitis. Dis Colon Rectum. 1996; 39:88–100. PMID:
8601363.
Article
2. Green BT, Tendler DA. Ischemic colitis: a clinical review. South Med J. 2005; 98:217–222. PMID:
15759953.
Article
3. Elder K, Lashner BA, Al Solaiman F. Clinical approach to colonic ischemia. Cleve Clin J Med. 2009; 76:401–409. PMID:
19570972.
Article
4. Binns JC, Isaacson P. Age-related changes in the colonic blood supply: their relevance to ischaemic colitis. Gut. 1978; 19:384–390. PMID:
658768.
Article
5. Frossard JL, Spahr L, Queneau PE, Armenian B, Brüdler MA, Hadengue A. Ischemic colitis during pregnancy and contraceptive medication. Digestion. 2001; 64:125–127. PMID:
11684827.
Article
6. Cushman M, Kuller LH, Prentice R, et al. Estrogen plus progestin and risk of venous thrombosis. JAMA. 2004; 292:1573–1580. PMID:
15467059.
Article
7. Tyler ET. Oral contraception and venous thrombosis. JAMA. 1963; 185:131–132.
Article
8. Martinelli I, Mannucci PM, De Stefano V, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood. 1998; 92:2353–2358. PMID:
9746774.
Article
9. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996; 88:3698–3703. PMID:
8916933.
Article
10. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993; 342:1503–1506. PMID:
7902898.
Article
11. Meijers JC, Middeldorp S, Tekelenburg W, et al. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives. Thromb Haemost. 2000; 84:9–14. PMID:
10928462.
12. Tchaikovski SN, Rosing J. Mechanisms of estrogen-induced venous thromboembolism. Thromb Res. 2010; 126:5–11. PMID:
20163835.
Article
13. de Visser MC, van Hylckama Vlieg A, Tans G, et al. Determinants of the APTT- and ETP-based APC sensitivity tests. J Thromb Haemost. 2005; 3:1488–1494. PMID:
15978106.
Article
14. Odlind V, Milsom I, Persson I, Victor A. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta Obstet Gynecol Scand. 2002; 81:482–490. PMID:
12047300.
Article
15. Kemmeren JM, Algra A, Meijers JC, et al. Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor V Leiden mutation: a randomized trial. Blood. 2004; 103:927–933. PMID:
14551147.
16. Pomp ER, le Cessie S, Rosendaal FR, Doggen CJ. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol. 2007; 139:289–296. PMID:
17897305.
Article
17. Brandt LJ, Feuerstadt P, Blaszka MC. Anatomic patterns, patient characteristics, and clinical outcomes in ischemic colitis: a study of 313 cases supported by histology. Am J Gastroenterol. 2010; 105:2245–2252. PMID:
20531399.
Article
18. Carpenter HA, Talley NJ. The importance of clinicopathological correlation in the diagnosis of inflammatory conditions of the colon: histological patterns with clinical implications. Am J Gastroenterol. 2000; 95:878–896. PMID:
10763932.
Article
19. Yoon SM. Ischemic colitis: how can it be beneficial? Paper presented at: The 2nd Endofest-Korea. 2011 Mar 26; Seoul, Korea.
20. Paterno F, McGillicuddy EA, Schuster KM, Longo WE. Ischemic colitis: risk factors for eventual surgery. Am J Surg. 2010; 200:646–650. PMID:
21056146.
Article